Abstract:. Researchers utilized a two-vector system, consisting of an enveloped delivery vehicle and an adeno-associated virus to deliver CRISPR tools and a large DNA payload, to achieve stable and ...
Although T cell–based therapies have shown great promise for treatment of hematologic malignancies, many barriers limit their success in solid tumor types. One such limitation is the scarcity of ...
To help defray the rising costs of initial manuscript screening and publication, the AACR journals levy fees as detailed herein. Authors are required to confirm at the time of submission that they ...
You do not currently have access to this content.
*Corresponding Author: Sandra J. Casak, Office of Oncology Drugs, CDER, U.S. Food and Drug Administration, WO22 Room 2200, 10903 New Hampshire Avenue, Silver Spring ...
, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results